OBJECTIVE: Determine the relationship between caffeine, catecholamines, and alertness during prolonged wakefulness. METHODS: Following 49 h of prolonged wakefulness, each of 50 healthy males (18-32 years) orally ingested either aplacebo or one of three doses of caffeine, 2.1 (low), 4.3 (medium), or 8.6 mg kg-1 body weight (high), in a randomized double-blind design. Wakefulness continued for an additional 12 h during which venous blood samples were collected for catecholamine and caffeine analysis [determined using high-performance liquid chromatography (HPLC)]. A sleep latency test, the Stanford sleepiness scale, and a choice reaction time test were administered periodically during the post-dosing period and served as measures of alertness (physiological, subjective, and behavioral, respectively). RESULTS:Caffeine had no significant effect on noradrenaline, but adrenaline was significantly increased between 1 h and 4 h post-dosing in the high dose group compared with a placebo group. Following caffeine administration, responses to sleep latency, sleepiness scores, and reaction time scores showed dose-related changes that were exhibited by significant correlation coefficients. CONCLUSION: The results indicate that high doses of caffeine have a significant and beneficial effect on alertness during prolonged wakefulness.
RCT Entities:
OBJECTIVE: Determine the relationship between caffeine, catecholamines, and alertness during prolonged wakefulness. METHODS: Following 49 h of prolonged wakefulness, each of 50 healthy males (18-32 years) orally ingested either a placebo or one of three doses of caffeine, 2.1 (low), 4.3 (medium), or 8.6 mg kg-1 body weight (high), in a randomized double-blind design. Wakefulness continued for an additional 12 h during which venous blood samples were collected for catecholamine and caffeine analysis [determined using high-performance liquid chromatography (HPLC)]. A sleep latency test, the Stanford sleepiness scale, and a choice reaction time test were administered periodically during the post-dosing period and served as measures of alertness (physiological, subjective, and behavioral, respectively). RESULTS:Caffeine had no significant effect on noradrenaline, but adrenaline was significantly increased between 1 h and 4 h post-dosing in the high dose group compared with a placebo group. Following caffeine administration, responses to sleep latency, sleepiness scores, and reaction time scores showed dose-related changes that were exhibited by significant correlation coefficients. CONCLUSION: The results indicate that high doses of caffeine have a significant and beneficial effect on alertness during prolonged wakefulness.
Authors: Gillian A Beauchamp; Amberly R Johnson; Barbara I Crouch; Matthew Valento; B Zane Horowitz; Robert G Hendrickson Journal: J Med Toxicol Date: 2016-04-04
Authors: Felix von Bechtolsheim; Florian Oehme; Michael Maruschke; Sofia Schmidt; Alfred Schneider; Jürgen Weitz; Marius Distler; Sebastian Bodenstedt; Isabel Funke; Stefanie Speidel; Soeren Torge Mees Journal: Surg Endosc Date: 2021-11-15 Impact factor: 3.453
Authors: Gary H Kamimori; Tom M McLellan; Charmaine M Tate; David M Voss; Phil Niro; Harris R Lieberman Journal: Psychopharmacology (Berl) Date: 2014-12-21 Impact factor: 4.530
Authors: Harry P Cintineo; Marissa L Bello; Alexa J Chandler; Thomas D Cardaci; Bridget A McFadden; Shawn M Arent Journal: J Int Soc Sports Nutr Date: 2022-08-18 Impact factor: 4.948